Oliver Stoß
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- RNA and protein synthesis mechanisms 5
- RNA Research and Splicing 5
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 1
- Oncology 6
- HER2/EGFR in Cancer Research 6
- Co-authors
- Stefan Stamm (5 shared papers)Josef Rüschoff (5 shared papers)Peter Stoilov (2 shared papers)Yung‐Jue Bang (1 shared paper)Keun-Wook Lee (1 shared paper)Michaela Lehle (1 shared paper)Feng-yi Feng (1 shared paper)Vivian Ng (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)Expert Opinion on Therapeutic Targets (2 papers)Journal of Clinical Oncology (1 paper)Modern Pathology (1 paper)DNA and Cell Biology (1 paper)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Oliver Stoß
16 papers receiving 1.0k citations
Oliver Stoß's Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 447
- Gastroenterology 63
- Pulmonary and Respiratory Medicine 231
- Radiology, Nuclear Medicine and Imaging 162
- Cancer Research 99
Countries citing papers authored by Oliver Stoß
This map shows the geographic impact of Oliver Stoß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Stoß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Stoß more than expected).
Fields of papers citing papers by Oliver Stoß
This network shows the impact of papers produced by Oliver Stoß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Stoß. The network helps show where Oliver Stoß may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Stoß, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer Hit paper breakdown → | 2014 | 437 |
| 2 | 2009 | 148 | |
| 3 | 2000 | 129 | |
| 4 | 2001 | 83 | |
| 5 | 1999 | 52 | |
| 6 | 2015 | 43 | |
| 7 | 2004 | 40 | |
| 8 | 1999 | 36 | |
| 9 | 2006 | 26 | |
| 10 | HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer | 2007 | 25 |
| 11 | 2020 | 6 | |
| 12 | 2003 | 5 | |
| 13 | 2006 | 5 | |
| 14 | 2002 | 3 | |
| 15 | 2004 | 3 | |
| 16 | Her2-Diagnostik beim Magenkarzinom: Was ist anders im Vergleich zum Mammakarzinom? | 2010 | 1 |
About Oliver Stoß
Oliver Stoß is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), RNA and protein synthesis mechanisms (5 papers), RNA Research and Splicing (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), RNA modifications and cancer (3 papers), Gastric Cancer Management and Outcomes (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Oncology (447 citations), Gastroenterology (63 citations), Pulmonary and Respiratory Medicine (231 citations), Radiology, Nuclear Medicine and Imaging (162 citations) and Cancer Research (99 citations). Oliver Stoß has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Stefan Stamm, Josef Rüschoff, Peter Stoilov, Yung‐Jue Bang, Keun-Wook Lee, Michaela Lehle, Feng-yi Feng, Vivian Ng, Shunchang Jiao and Eric Van Cutsem. Their work appears in journals such as Journal of Biological Chemistry, Expert Opinion on Therapeutic Targets, Journal of Clinical Oncology, Modern Pathology and DNA and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.